Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Tango Therapeutics Inc before investing.

In this article, we go over a few key elements for understanding Tango Therapeutics Inc’s stock price such as:

• Tango Therapeutics Inc’s current stock price and volume
• Why Tango Therapeutics Inc’s stock price changed recently
• Upgrades and downgrades for TNGX from analysts
• TNGX’s stock price momentum as measured by its relative strength

About Tango Therapeutics Inc (TNGX)

Before we jump into Tango Therapeutics Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering precision medicine for the treatment of cancer. The Company leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. Its lead program, TNG908, is an methylthioadenosine (MTA)-cooperative inhibitor of protein arginine methyltransferase 5 (PRMT5) designed to work selectively in cancer cells with an methylthioadenosine phosphorylase (MTAP) deletion. Its TNG260 is a first-in-class Co-repressor of Repressor Element-1 Silencing Transcription (CoREST) inhibitor. The Company's programs also include TNG348 and TNG462. TNG348 is an allosteric inhibitor of ubiquitin-specific protease (USP1).

Want to learn more about Tango Therapeutics Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Tango Therapeutics Inc.

Tango Therapeutics Inc’s Stock Price as of Market Close

As of June 26, 2024, 4:00 PM, CST, Tango Therapeutics Inc’s stock price was $8.87.

Tango Therapeutics Inc is down 4.21% from its previous closing price of $9.26.

During the last market session, Tango Therapeutics Inc’s stock traded between $9.23 and $10.32. Currently, there are 108.17 million shares of Tango Therapeutics Inc stock available for purchase.

Unfortunately, Tango Therapeutics Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Tango Therapeutics Inc Stock Price History

Tango Therapeutics Inc’s (TNGX) price is currently up 28.18% so far this month.

During the month of June, Tango Therapeutics Inc’s stock price has reached a high of $10.44 and a low of $6.70.

Over the last year, Tango Therapeutics Inc has hit prices as high as $13.03 and as low as $2.88. Year to date, Tango Therapeutics Inc’s stock is up 22.34%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Tango Therapeutics Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of June 25, 2024, there were 4 analysts who downgraded Tango Therapeutics Inc’s stock and 4 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Tango Therapeutics Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Tango Therapeutics Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Tango Therapeutics Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Tango Therapeutics Inc (TNGX) by visiting AAII Stock Evaluator.

Relative Price Strength of Tango Therapeutics Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 25, 2024, Tango Therapeutics Inc has a weighted four-quarter relative price strength of 43.08%, which translates to a Momentum Score of 98 and is considered to be Very Strong.

Want to learn more about how Tango Therapeutics Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Tango Therapeutics Inc Stock Price: Bottom Line

As of June 26, 2024, Tango Therapeutics Inc’s stock price is $8.87, which is down 4.21% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Tango Therapeutics Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.